Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by jewel9mon Apr 10, 2019 10:03am

93 Views

Post# 29606350

RE:Congratulations to all !!!!!!!!!!!!!!!!!!!!!!

I agree 100% with you.

This is just a start of what is to come. China deal, which may be done in the next 2 weeks and NA deal to follow.

Remember this is the venture and alot of games will be played to pull shares from your hands.
HOLD tight and enjoy the ride.

Oh yes there is SGLT and Lip.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec